168 related articles for article (PubMed ID: 1540480)
1. Effects of age, sex and the oral contraceptive on the platelet membrane fibrinogen binding site (glycoprotein IIb/IIIa).
Cahill M; Mistry R; Chapman C; Wood JK; Barnett DB
Br J Clin Pharmacol; 1992 Jan; 33(1):11-5. PubMed ID: 1540480
[TBL] [Abstract][Full Text] [Related]
2. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast.
Battersby S; Robertson BJ; Anderson TJ; King RJ; McPherson K
Br J Cancer; 1992 Apr; 65(4):601-7. PubMed ID: 1562470
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
[TBL] [Abstract][Full Text] [Related]
4. Changes in insulin receptors during oral contraception.
De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
[TBL] [Abstract][Full Text] [Related]
5. Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery.
Robinson GE; Burren T; Mackie IJ; Bounds W; Walshe K; Faint R; Guillebaud J; Machin SJ
BMJ; 1991 Feb; 302(6771):269-71. PubMed ID: 1998792
[TBL] [Abstract][Full Text] [Related]
6. Increase in endogenous fibrinolysis and platelet activity during exercise in young volunteers.
Beisiegel B; Treese N; Hafner G; Meyer J; Darius H
Agents Actions Suppl; 1992; 37():183-9. PubMed ID: 1378684
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of platelet lipids in relation to aggregation in women using oral contraceptives.
Ciavatti M; Davenas E; Blache D; Monnier MA; Renaud S
Contraception; 1982 Jun; 25(6):629-38. PubMed ID: 7116849
[TBL] [Abstract][Full Text] [Related]
8. Reference limits of plasma fibrinogen.
Tarallo P; Henny J; Gueguen R; Siest G
Eur J Clin Chem Clin Biochem; 1992 Nov; 30(11):745-51. PubMed ID: 1489846
[TBL] [Abstract][Full Text] [Related]
9. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
Peerschke EI
J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
[TBL] [Abstract][Full Text] [Related]
10. An epidemiological study of the haemostatic and other effects of oral contraceptives.
Meade TW; Brozović M; Chakrabarth R; Howarth DJ; North WR; Stirling Y
Br J Haematol; 1976 Nov; 34(3):353-64. PubMed ID: 990177
[TBL] [Abstract][Full Text] [Related]
11. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. I. Quantal activation of platelet subpopulations varies with adenosine diphosphate concentration.
Frojmovic MM; Mooney RF; Wong T
Biophys J; 1994 Nov; 67(5):2060-8. PubMed ID: 7858143
[TBL] [Abstract][Full Text] [Related]
13. Sequential study of plasma euglobulin fibrinolytic activity during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
Jespersen J
Gynecol Obstet Invest; 1983; 15(5):266-74. PubMed ID: 6852646
[TBL] [Abstract][Full Text] [Related]
14. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
[TBL] [Abstract][Full Text] [Related]
15. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
[TBL] [Abstract][Full Text] [Related]
16. Differences between platelet and microparticle glycoprotein IIb/IIIa.
Nomura S; Suzuki M; Kido H; Yamaguchi K; Fukuroi T; Yanabu M; Soga T; Nagata H; Kokawa T; Yasunaga K
Cytometry; 1992; 13(6):621-9. PubMed ID: 1451594
[TBL] [Abstract][Full Text] [Related]
17. A new method for the assay of exposed platelet fibrinogen receptor using a chemiluminescent label.
Katoh M; Chishima S; Kiuchi N; Ikeo T; Sasaki Y
Thromb Haemost; 1995 Dec; 74(6):1546-50. PubMed ID: 8772235
[TBL] [Abstract][Full Text] [Related]
18. The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering.
Isenberg WM; McEver RP; Phillips DR; Shuman MA; Bainton DF
J Cell Biol; 1987 Jun; 104(6):1655-63. PubMed ID: 3584243
[TBL] [Abstract][Full Text] [Related]
19. Hormonal contraception and platelet function.
Saleh AA; Ginsburg KA; Duchon TA; Dorey LG; Hirata J; Alshameeri RS; Dombrowski MP; Mammen EF
Thromb Res; 1995 May; 78(4):363-7. PubMed ID: 7631316
[TBL] [Abstract][Full Text] [Related]
20. Levels of protein S during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
Jespersen J; Nielsen MT
Gynecol Obstet Invest; 1989; 28(2):82-6. PubMed ID: 2529199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
